Global Genome Sequencing Market Growth Outlook and Opportunities By Key Players Bio-Rad Laboratories, Inc., BGI, Danaher., GENERAL ELECTRIC COMPANY, Eppendorf AG, Abbott & Others

Genome sequencing market is expected to rise to an estimated value of USD 47.97 billion by 2026 registering a substantial CAGR of 13.95% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising government spending, rise in the applications of genomics and the declining sequencing costs.

This Genome sequencing report analyzes the market status, growth rate, future trends, market drivers, opportunities, challenges, entry barriers, risks, sales channels, and distributors. Genome sequencing market research report is formed with a nice combination of industry insight, smart solutions, practical solutions and newest technology to give better user experience. Businesses can obtain details about market drivers and market restraints which assist them to take presumption about reducing or increasing the production of particular product. Genome sequencing market analysis report comprises of historic data, present market trends, market environment, technological innovation, upcoming technologies and the technical progress in the related industry.

Ask For Complimentary Sample PDF| Request At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-genome-sequencing-market

Few of the major market competitors currently working in the genome sequencing market are Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., BGI, Danaher., GENERAL ELECTRIC COMPANY, Eppendorf AG, Abbott, LI-COR, Inc., Siemens, PerkinElmer Inc., Macrogen Inc., DNASTAR, Geneious, Myriad Genetics, Inc., amongst others.

Market Drivers

Increased funding and initiative by the government to promote genome sequencing and its varied applicability in numerous projects accelerates the growth of this market

Reduction in the costs of genome sequencing further boosts the growth of this market

Growing applicability of genomes in various areas including diagnosis, animal research, agriculture, drug discovery, food and beverages etc.

With changing environment of operations and advancements in technology, several new opportunities have been created thereby leading to the entry of new players and start-ups that would foster the growth of this market

Market Restraints

Expensive and high cost of genome equipments

Lack of skilled professionals

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type

Get detailed toc @ https://databridgemarketresearch.com/toc/?dbmr=global-genome-sequencing-market

Segmentation: Global Genome Sequencing Market

By Product and Services

Consumables

Systems & Software

Services

By Technology

Sequencing

Microarray

Nucleic Acid Extraction & Purification

Other Technologies

By Applications

Diagnostics

Drug Discovery & Development

Precision Medicine

Agriculture & Animal Research

Other Applications

By End User

Pediatric

Research Centers

Academic & Government Institutes

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies

Other End Users

By Geography

North America

South America

Europe

Asia-Pacific

Middle East and Africa

Key Developments in the Market:

In November 2018, Illumina Inc., the genome sequencing giants acquires Pacific Biosciences, a developer and manufacturer of gene sequencing. With this acquisition it would combine its own short genome/DNA sequencing with the long-read sequencing technology of Pacific Biosciences in order to maintain its dominant position in the genomes market, and continue to remain the market leader. With this, it would be able to enter into a new market especially in the areas of rare and undiagnosed diseases, thereby expanding its customer base and providing innovative solutions and services to its clients.

In June 2017, GATC Biotech AG, a leading company in genome sequencing was acquired by Eurofins, the global pioneering leader in bio-analytical testing including DNA, genome testing. With this acquisition Eurofins would expand its product portfolio and better serve its present and future clients by strengthening its genomics and genomic sequencing testing by acquiring the market leader in genomes.

Inquiry For Customize Report With Discount at : https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-genome-sequencing-market

Customization of the Report:

All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com

About DataBridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.